[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100396730":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":49,"collaborators":10,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":10,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Medical University of Vienna","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"VA-ECMO patients",null,"VA-ECMO support because of low cardiac output.",[13],"Device: VA-ECMO",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","VA-ECMO","Deployment of extracorporeal membrane oxygenation cardiac assist device.",[9],[21],{"name":22,"affiliation":5,"role":23},"Martin Dworschak, MD, MBA","PRINCIPAL_INVESTIGATOR",[25],{"name":22,"role":26,"phone":27,"phoneExt":28,"email":29},"CONTACT","+43-1-40400","41090","martin.dworschak@meduniwien.ac.at",[31],{"facility":5,"status":32,"city":33,"state":10,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"RECRUITING","Vienna","1090","Austria","AT",{"type":38,"coordinates":39},"Point",[40,41],16.37208,48.20849,{"lat":41,"lon":40},[44,45],{"name":22,"role":26,"phone":27,"phoneExt":28,"email":29},{"name":46,"role":26,"phone":27,"phoneExt":47,"email":48},"Martin Bernardi, MD","64100","martin.bernardi@meduniwien.ac.at",{"type":23,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Dr. Martin Dworschak","Assoc. Prof. of Anesthesia and Intensive Care Medicine","100396730","validation-of-continuous-transcutaneous-carbon-dioxide-monitoring-in-va-ecmo-patients-100396730",false,"NCT04445909","Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients","Validation of Continuously Determined Transcutaneous Carbon Dioxide Partial Pressures in Patients Supported with Veno-arterial Extracorporeal Membrane Oxygenation","Inclusion Criteria:\n\n* Low cardiac output requiring VA-ECMO support.\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years","ALL","18 Years","90 Years",{"count":63,"type":64},30,"ESTIMATED","OBSERVATIONAL","Carbon dioxide in patients on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is eliminated via respirator as well as via the oxygenator's membrane of the ECMO machine. Consequently, monitoring of end-tidal carbon dioxide tensions is limited, which can result in marked swings towards non-physiological values. Hyper- and hypocapnia, however, can have detrimental effects on organ perfusion in a great number of patients supported with VA-ECMO. Continuous, rapidly applicable monitoring of reliable carbon dioxide measures would therefore be extremely helpful to prevent harmful deviations from the norm. The investigators therefore try to assess the accuracy and the precision of continuously measured non-invasive transcutaneous carbon dioxide partial pressures when compared with tensions determined by blood gas analysis.",[68],"Carbon Dioxide",[70,71,72,73,74,75],"ECMO","Carbon dioxide elimination","Organ perfusion","Low cardiac output","Monitoring","Critical Care","2024-12-01",{"date":78,"type":79},"2024-12-04","ACTUAL",{"date":81,"type":79},"2019-11-18",{"date":83,"type":64},"2025-12-31",{"name":5,"class":6},1]